Bortezomib-combination based therapy in relapsed-refractory myeloma patients. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2026 Sep. 24];2(5). Available from: https://journals.pagepress.net/hmr/article/view/381